首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators
【24h】

Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators

机译:在结肠直肠癌筛选期间通过内窥镜检查去除PT1肿瘤的管理:结果和治疗质量指标

获取原文
获取原文并翻译 | 示例
       

摘要

IntroductionLimited information is available about outcomes of patients with malignant adenomas endoscopically resected at screening. The aim of the study was to evaluate diagnostic and therapeutic quality indicators and to correlate them with clinical and surgical outcomes. Materials and methodsWe reviewed endoscopic and histology characteristics of all pT1 tumours endoscopically removed at the time of colonoscopy assessment in subjects with a positive screening test result in the context of a population-based program. Results392 pT1 tumours were completely removed by endoscopy (en-bloc?=?86.7%, piecemeal?=?13.3%) and the histology report was considered complete in 83.2% of cases. Treatment was limited to endoscopic excision for 120 patients (30.7%, Group 1), 272 (69.3%, Group 2) underwent radicalisation surgery. In patients who had at least 1 lymph node examined, the rate of nodal involvement was 5.4% (13/239); no metastatic node was found in the 21 (27.6%) out of 76 patients with low-risk adenomas, who underwent surgery. ConclusionRisk of nodal involvement in colorectal pT1 tumours is well predicted by known histologic features also in a screening setting, although it was lower than among patients from clinical series. Surgical overtreatment is still significantly present and there is ample room for improvement regarding diagnostic and therapeutic flow-chart.
机译:介绍的信息有关在筛选时内镜检查的恶性腺腺瘤患者的结果。该研究的目的是评估诊断和治疗质量指标,并将它们与临床和外科结果相关联。材料和方法综述了在基于人口的持续筛选试验的对象中的对象中的结肠镜检查时内窥镜检查的内窥镜和组织学特征,在对象的正面筛选试验结果。结果392通过内窥镜检查完全除去PT1肿瘤(EN-BLOC?= 86.7%,零碎?= 13.3%),并且组织学报告被认为是83.2%的病例。治疗限于120例患者的内窥镜切除(30.7%,第1组),272(69.3%,第2组)接受激进手术。在检查至少1个淋巴结的患者中,节点参与的速率为5.4%(13/239);在76名患者中,21例(27.6%)未发现转移节点,患有手术的低风险腺瘤的76名患者。结论结肠直肠PT1肿瘤的节点参与的阶段也通过已知的组织学特征在筛选环境中预测,尽管它低于来自临床系列的患者。仍然显着存在手术过处,并且有关诊断和治疗流程图的有关改进的余地。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号